Clinical Trial Update: Xeomin vs Botox for Treatment of Overactive Bladder Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Xeomin and Botox for overactive bladder syndrome is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder Syndrome

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Overactive Bladder Syndrome | Phase 2 | Status: UNKNOWN